This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Deciphera Pharmaceuticals, LLC. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations in Cancer Treatment by Xiaoyan Li
Introduction
Xiaoyan Li is a prominent inventor based in Lexington, MA (US). He has made significant contributions to the field of oncology, particularly in the treatment of gastrointestinal stromal tumors. His innovative approaches have the potential to improve patient outcomes and advance cancer therapies.
Latest Patents
Xiaoyan Li holds a patent for "Methods of treating gastrointestinal stromal tumors." This patent describes methods for treating patients suffering from these tumors by administering a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof. This innovation represents a crucial step forward in targeted cancer treatment.
Career Highlights
Xiaoyan Li is currently associated with Deciphera Pharmaceuticals, LLC, where he continues to work on groundbreaking cancer therapies. His expertise and dedication to research have positioned him as a key figure in the pharmaceutical industry.
Collaborations
Xiaoyan collaborates with Jing Wang, a talented woman in the field, contributing to the advancement of cancer treatment methodologies. Their partnership exemplifies the importance of teamwork in scientific research.
Conclusion
Xiaoyan Li's work in developing methods for treating gastrointestinal stromal tumors showcases his commitment to innovation in cancer therapy. His contributions are paving the way for more effective treatments and improving the lives of patients facing this challenging disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile